Clearing the path for biological product commercialization

Complex and inconsistent global regulations for agricultural biologicals can make it hard to realize the full scope of commercial opportunities. Aligning commercial and regulatory strategies at the earliest opportunity streamlines the journey to broader market access.

As the push for more sustainable agriculture increases demand for biologicals, innovation is accelerating. But when it comes to the commercialization of biological products, regulatory complexity and disharmony can slow things down.

While it is generally agreed that biologicals are derived from living organisms or produced using living systems, the way they are classified and regulated varies greatly between markets. This lack of consensus can be a significant obstacle to market entry. Agrichemical companies need to systematically align products with markets’ specific registration/authorization demands.